Tony Galliani

VP, Commercial Strategy

Tony’s role is to create, develop and lead the Beta Bionics nationwide sales team and to execute our company’s strategic vision. Tony has over 22 years of business development, sales leadership and commercial operations experience in diabetes medical devices. Some of his previous experience includes Companion Medical, Tandem Diabetes, and Animas (Johnson & Johnson). Tony most recently served as VP of Business Development at Bigfoot Biomedical, launching its first product in the US, and has been involved in the launch of over 20 new products in the diabetes space. Tony earned a BA in Business Administration from California State University, Fullerton.

Beta Bionics is a public benefit corporation.

We are committed to balancing purpose with profit and giving back to society as we fulfill our public benefit mission.

Safety Information – The iLet Bionic Pancreas System is indicated for use by people with type 1 diabetes 6 years of age and older. The iLet Bionic Pancreas requires prescription by a physician. Refer to the iLet Bionic Pancreas System User Guide at www.betabionics.com/resouces/user-guides, or for complete safety information including indications, contraindications, warnings, cautions, compatible devices, compatible drugs and instructions, refer to www.betabionics.com/resources/safety. DO NOT start to use the iLet Bionic Pancreas System without adequate training. Incorrect use may result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.

Medical Disclaimer – This website is for information only and is not a substitute for medical advice and/or services from a healthcare provider. All personal health care decisions and treatment should be discussed with a healthcare provider who is familiar with your individual needs.